Ticker,Title,Link
RVMD,Wall Street Analysts Are Bullish on Top Healthcare Picks,8/13/2024 12:40:57 PM
RVMD,Revolution Medicines: A Strong Buy on Robust Financials and Promising Clinical Pipeline,8/12/2024 10:18:43 AM
RVMD,Revolution Medicines Maintains Buy Rating Amid Promising Clinical Progress and Strong Financial Standing,8/9/2024 12:24:51 PM
RVMD,"Analysts Conflicted on These Healthcare Names: Revolution Medicines (RVMD), Personalis (PSNL) and Zimmer Biomet Holdings (ZBH)",8/8/2024 1:42:57 PM
RVMD,Revolution Medicines Reports Second Quarter 2024 Financial Results and Update on Corporate Progress,8/7/2024 10:05:41 PM
RVMD,Revolution Medicines earnings: here's what to expect,8/6/2024 3:01:13 PM
RVMD,"Revolution Medicines to Report Financial Results for Second Quarter 2024 After Market Close on August 7, 2024",7/31/2024 10:05:11 PM
RVMD,Outperform Rating with Raised Price Target for Revolution Medicines Amid Promising Oncology Trials,7/24/2024 5:55:51 AM
RVMD,Barclays Remains a Buy on Revolution Medicines (RVMD),7/18/2024 8:20:53 AM
RVMD,Microsoft To Rally Around 6%? Here Are 10 Top Analyst Forecasts For Tuesday,7/16/2024 2:05:44 PM
RVMD,Buy Rating Affirmed for Revolution Medicines on Promising RMC-6236 Clinical Data and Market Potential,7/15/2024 6:45:22 PM
RVMD,15 Healthcare Stocks Hit New Highs: Did You Spot These Winners? ,7/14/2024 7:59:35 AM
RVMD,"Catalyst Watch: Netflix, Taiwan Semi, Amazon, and HashiCorp are in the spotlight",7/12/2024 7:00:29 PM
RVMD,Revolution Medicines Announces Publication Demonstrating Robust Anti-Tumor Activity of RAS(ON) Inhibitors in Preclinical Models of Refractory KRAS-Mutated Non-Small Cell Lung Cancer,7/11/2024 6:00:53 PM
RVMD,Revolution Medicines’s RMC-6236 Shows Promise in Oncology: Analyst Maintains Buy Rating with $48 Target,7/10/2024 9:16:20 AM
RVMD,"Revolution Medicines to Provide Update on RMC-6236 Pancreatic Ductal Adenocarcinoma Clinical Program on July 15, 2024",7/8/2024 10:05:00 PM
RVMD,TD Cowen Issues a Buy Rating on Revolution Medicines (RVMD),6/25/2024 11:45:10 AM
RVMD,The 7 Most Undervalued Under-$50 Stocks to Buy in June 2024,6/8/2024 1:00:00 PM
RVMD,Revolution Medicines to Participate in Goldman Sachs 45th Annual Global Healthcare Conference,6/5/2024 10:05:28 PM
RVMD,The 3 Most Undervalued Biotech Stocks to Buy in June 2024,6/4/2024 10:00:00 AM
RVMD,"Viking, CRISPR, Intellia among potential M&A targets: Wells Fargo",5/25/2024 2:24:03 PM
RVMD,Oppenheimer Remains a Buy on Revolution Medicines (RVMD),5/14/2024 11:56:11 AM
RVMD,Revolution Medicines (RVMD) Gets a Buy from Bank of America Securities,5/13/2024 1:35:14 PM
RVMD,"Analysts’ Top Healthcare Picks: Revolution Medicines (RVMD), Keros Therapeutics (KROS)",5/10/2024 5:20:10 AM
RVMD,J.P. Morgan Sticks to Its Buy Rating for Revolution Medicines (RVMD),5/9/2024 12:27:35 PM
RVMD,Revolution Medicines Reports First Quarter 2024 Financial Results and Update on Corporate Progress,5/8/2024 10:02:54 PM
RVMD,What Wall Street expects from Revolution Medicines's earnings,5/7/2024 3:01:13 PM
RVMD,"Revolution Medicines to Report Financial Results for First Quarter 2024 After Market Close on May 8, 2024",5/1/2024 10:05:56 PM
RVMD,"Analysts Are Bullish on Top Healthcare Stocks: Intuitive Surgical (ISRG), Revolution Medicines (RVMD)",4/19/2024 11:30:12 AM
RVMD,Oppenheimer Sticks to Their Buy Rating for Revolution Medicines (RVMD),4/12/2024 11:47:12 AM
RVMD,Why Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session,4/10/2024 8:07:06 PM
RVMD,"Revolution Medicines Announces Publication on the Discovery of and Translational Research for RMC-6236, an Investigational RAS(ON) Multi-Selective Tri-Complex Inhibitor Designed to Block Full...",4/9/2024 9:34:07 PM
RVMD,Revolution Medicines Announces Publications on the Discovery and Preclinical Profile of Representative of a New Class of RAS(ON) Multi-Selective Inhibitors Designed to Block Full Spectrum of...,4/8/2024 5:36:55 PM
RVMD,Revolution Medicines to Participate in Upcoming Investor Conferences,4/4/2024 10:05:04 PM
RVMD,Revolution Medicines to Deliver Multiple Presentations at the Upcoming American Association for Cancer Research Annual Meeting 2024,3/28/2024 9:05:40 PM
RVMD,Buy Rating on Revolution Medicines Amid Promising RMC-6236 Trials for Multiple Cancer Treatments,3/11/2024 9:05:34 AM
RVMD,Cantor sees strong year ahead for oncology M&A,3/10/2024 5:08:00 PM
RVMD,Morgan Stanley Maintains Equal-Weight Rating for Revolution Medicines: Here's What You Need To Know,3/8/2024 6:00:17 PM
RVMD,Revolution Medicines (RVMD) Receives a Buy from TD Cowen,3/7/2024 12:15:34 PM
RVMD,Buy Rating Affirmed for Revolution Medicines: Advancing RAS Inhibitors and Strong Financial Outlook,2/28/2024 4:36:36 AM
RVMD,"Analysts Are Bullish on Top Healthcare Stocks: Celldex (CLDX), Revolution Medicines (RVMD)",2/27/2024 1:30:33 PM
RVMD,Revolution Medicines Reports Fourth Quarter and Full Year 2023 Financial Results and Update on Corporate Progress,2/26/2024 10:05:50 PM
RVMD,Notable earnings after Monday's close,2/25/2024 10:35:04 PM
RVMD,"Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2023 After Market Close on February 26, 2024",2/20/2024 10:05:47 PM
RVMD,"Corvex Management buys Illumina, exits Apple, TKO",2/14/2024 10:06:13 PM
RVMD,"SYM, VRNS and RVMD are among after hour movers",2/5/2024 9:55:17 PM
RVMD,Revolution Medicines to Participate in Upcoming Investor Conferences,2/1/2024 10:05:00 PM
RVMD,Revolution Medicines to Present at 42nd Annual J.P. Morgan Healthcare Conference,1/4/2024 1:00:08 PM
RVMD,Pharma’s Frontline: 3 Stocks Driving Revolutionary Drug Development,12/15/2023 10:04:19 PM
RVMD,3 Biotech Stocks That Could Boom or Bust by 2025,11/16/2023 10:35:36 PM
RVMD,Revolution Medicines Completes Acquisition of EQRx,11/9/2023 3:10:58 PM
RVMD,Revolution Medicines and EQRx Stockholders Approve EQRx Acquisition,11/8/2023 5:30:46 PM
RVMD,What 6 Analyst Ratings Have To Say About Revolution Medicines,11/7/2023 9:00:48 PM
RVMD,Revolution Medicines Reports Third Quarter 2023 Financial Results and Update on Corporate Progress,11/6/2023 10:05:18 PM
RVMD,"Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Revolution Medicines Stockholders Vote “FOR” Proposed Acquisition of EQRx, Inc.",11/1/2023 12:00:00 PM
RVMD,"Revolution Medicines to Report Financial Results for Third Quarter 2023 After Market Close on November 6, 2023",10/31/2023 9:15:00 PM
RVMD,Wall Street Analysts Are Bullish on Top Healthcare Picks,10/26/2023 10:43:49 AM
RVMD,Revolution Medicines Earns Buy Rating Based on Promising Phase I Data and Strong RAS Pathway Development Prospects,10/25/2023 6:09:56 AM
RVMD,"Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (ISRG), Editas Medicine (EDIT) and Revolution Medicines (RVMD)",10/24/2023 12:21:25 PM
RVMD,Crude Oil Falls Sharply; Apollomics Shares Plunge,10/23/2023 8:39:29 PM
RVMD,Revolution Medicines Presents Promising Clinical Activity and Safety Data from Phase 1/1b Trial of RMC-6236,10/22/2023 8:30:28 AM
RVMD,Promising Efficacy Trends and Positive Updates on RAS ON Platform Bolster Confidence in Revolution Medicines: A Buy Rating Recommendation,10/17/2023 4:48:18 AM
RVMD,"Lululemon, PCTEL, Consolidated Communications, Other Stocks Jumping Higher On Monday",10/16/2023 6:08:15 PM
RVMD,Revolution Medicines Presents Encouraging Clinical Data for RMC-6236 and RMC-6291 at 2023 Triple Meeting,10/13/2023 5:50:29 PM
RVMD,Expert Ratings for Revolution Medicines,10/12/2023 4:00:39 PM
RVMD,Hold Rating on Revolution Medicines amidst Evaluation of RMC-6236’s Efficacy against Targeted Tumors: An Analysis by Alec Stranahan,10/6/2023 12:26:43 PM
RVMD,Revolution Medicines to Present New Clinical Data at Major Oncology Conferences and Host Investor Webcast,10/4/2023 10:05:07 PM
RVMD,Stifel Maintains Buy Rating for Revolution Medicines: Here's What You Need To Know,9/21/2023 7:00:41 PM
RVMD,"Revolution Medicines Doses First Patient in Phase 1/1b Clinical Trial of RMC-9805, an Oral, Covalent, Mutant-Selective KRASG12D(ON) Inhibitor",9/19/2023 1:00:38 PM
RVMD,Revolution Medicines Announces Publication Describing Molecular Basis of Tri-Complex Inhibitors Targeting Oncogenic RAS(ON) Proteins,8/17/2023 10:05:58 PM
RVMD,Analyst Ratings for Revolution Medicines,8/9/2023 8:00:40 PM
RVMD,"Revolution Medicines GAAP EPS of -$0.92 misses by $0.09, revenue of $3.82M beats by $2.26M",8/8/2023 8:34:19 PM
RVMD,Revolution Medicines earnings preview: what to expect,8/7/2023 3:01:13 PM
RVMD,"SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RETA, EQRX, RVMD",8/2/2023 4:40:00 PM
RVMD,Why Aaron's Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session,8/1/2023 9:05:37 PM
RVMD,SVB Securities Sticks to Their Buy Rating for Revolution Medicines (RVMD),5/11/2023 4:46:02 PM
RVMD,The Latest Analyst Ratings for Revolution Medicines,5/9/2023 4:01:15 PM
RVMD,"Revolution Medicines GAAP EPS of -$0.72 beats by $0.10, revenue of $7.01M beats by $4.07M",5/8/2023 8:18:46 PM
RVMD,Where Is The Current Bull Market? Scan Of Stocks Gaining Over 20% Over The Past Week Almost Exclusively Yields Biotech Names,4/20/2023 2:07:07 PM
RVMD,"Analysts Offer Insights on Healthcare Companies: Owens & Minor (OMI), Sarepta Therapeutics (SRPT) and Revolution Medicines (RVMD)",4/17/2023 6:30:57 AM
RVMD,Where Revolution Medicines Stands With Analysts,4/12/2023 2:07:27 PM
RVMD,Revolution Medicines prices $300M stock offering,3/3/2023 10:30:09 AM
RVMD,Revolution Medicines shares slide ~7% afterhours on $300M stock offering,3/2/2023 12:23:07 AM
RVMD,Ladenburg Thalmann & Co. Sticks to Their Buy Rating for Revolution Medicines (RVMD),3/1/2023 10:15:08 AM
RVMD,"Dentsply Sirona, Chico's FAS, Kontoor Brands And Other Big Stocks Moving Higher On Tuesday",2/28/2023 4:40:02 PM
RVMD,"Revolution Medicines GAAP EPS of -$0.63 beats by $0.18, revenue of $15.33M beats by $7.53M",2/27/2023 9:10:20 PM
RVMD,Here's what to expect from Revolution Medicines's earnings report,2/26/2023 3:01:13 PM
RVMD,Where Revolution Medicines Stands With Analysts,12/14/2022 7:04:06 PM
RVMD,SVB Securities Sticks to Their Buy Rating for Revolution Medicines (RVMD),12/9/2022 5:55:31 AM
RVMD,Revolution Medicines to regain rights to cancer candidate from Sanofi,12/8/2022 5:27:09 PM
RVMD,SVB Securities Keeps Their Buy Rating on Revolution Medicines (RVMD),11/10/2022 4:35:18 AM
RVMD,Revolution Medicines to Participate in Upcoming Investor Conferences,11/9/2022 10:05:00 PM
RVMD,"Revolution Medicines GAAP EPS of -$0.87 misses by $0.02, revenue of $3.4M misses by $2.94M",11/7/2022 9:22:17 PM
RVMD,Revolution Medicines is about to announce its earnings — here's what Wall Street expects,11/6/2022 3:01:13 PM
RVMD,"Revolution Medicines to Report Financial Results for Third Quarter 2022 After Market Close on November 7, 2022",11/1/2022 9:05:00 PM
RVMD,‘Who Doesn’t Like a Bargain?’: Oppenheimer Suggests 2 Stocks to Buy,10/24/2022 3:07:19 PM
RVMD,"AAOI, HEAR and SSRM are among after hour movers",10/21/2022 9:27:15 PM
RVMD,Revolution Medicines promotes Jack Anders to CFO,9/2/2022 12:43:12 PM
RVMD,Revolution Medicines to Participate in Upcoming Investor Conferences,8/31/2022 10:05:00 PM
RVMD,"LegalZoom.com, Toast And Some Other Big Stocks Moving Higher On Friday",8/12/2022 5:59:07 PM
RVMD,Revolution Medicines Reports Second Quarter 2022 Financial Results and Update on Corporate Progress,8/9/2022 10:02:00 PM
RVMD,Here's what Wall Street expects from Revolution Medicines's earnings report,8/8/2022 3:01:13 PM
RVMD,"Revolution Medicines to Report Financial Results for Second Quarter 2022 After Market Close on August 9, 2022",7/28/2022 10:02:00 PM
RVMD,Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares,7/22/2022 10:02:00 PM
RVMD,Revolution Medicines Stock Is Getting Hammered: Here's Why,7/20/2022 4:21:18 PM
RVMD,Revolution Medicines Announces Commencement of Public Offering of Common Stock,7/19/2022 10:01:00 PM
RVMD,"Revolution Medicines Appoints Lorence Kim, M.D., Accomplished Health Care Industry Leader, to Board of Directors",7/13/2022 1:00:00 PM
RVMD,Amgen Lumakras combination data in lung cancer held until August - Reuters,7/12/2022 11:14:56 PM
RVMD,"Revolution Medicines Advances First RAS(ON) Inhibitor into Clinic, Dosing First Patient in Phase 1/1b Trial of RMC-6236",6/28/2022 1:00:00 PM
RVMD,Revolution Medicines to Participate in the 43rd Annual Goldman Sachs Global Healthcare Conference,6/9/2022 10:02:00 PM
RVMD,"Benzinga's Top Ratings Upgrades, Downgrades For May 20, 2022",5/20/2022 4:02:44 PM
RVMD,Revolution Medicines Reports First Quarter 2022 Financial Results and Update on Corporate Progress,5/9/2022 10:02:00 PM
RVMD,Here's what Wall Street expects from Revolution Medicines's earnings report,5/8/2022 3:01:13 PM
RVMD,"Revolution Medicines to Report Financial Results for First Quarter 2022 After Market Close on May 9, 2022",4/21/2022 10:05:00 PM
RVMD,"SPRB, RVMD and LYEL among after hour movers",4/8/2022 10:02:54 PM
RVMD,7 Stocks That Insiders Are Buying Now. Should You?,3/31/2022 12:33:41 PM
RVMD,Children's Place And 2 Other Stocks Bought By Insiders,3/25/2022 1:22:01 PM
RVMD,Revolution Medicines gains after $3.4M insider buying,3/22/2022 4:50:11 PM
RVMD,Insiders Buy More Than $19M Of 3 Stocks,3/10/2022 1:10:24 PM
RVMD,Revolution Medicines Announces Seven Oral Presentations at the Upcoming American Association for Cancer Research Annual Meeting 2022,3/9/2022 1:30:00 PM
RVMD,Insiders Buy More Than $3B Of 4 Stocks,3/7/2022 2:53:29 PM
RVMD,Revolution Medicines to Participate in Cowen 42nd Annual Health Care Conference,3/1/2022 10:05:00 PM
RVMD,Revolution Medicines Reports Fourth Quarter and Year-End 2021 Financial Results and Update on Corporate Progress,2/28/2022 10:05:00 PM
RVMD,Here's what Wall Street expects from Revolution Medicines's earnings,2/27/2022 3:01:13 PM
RVMD,"Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2021 After Market Close on February 28, 2022",2/22/2022 10:05:00 PM
RVMD,Revolution Medicines to Participate in Guggenheim Healthcare Talks 2022 Oncology Conference,2/3/2022 1:30:00 PM
RVMD,Revolution Medicines Reports Progress Across Pipeline of Targeted Therapeutics for RAS-Addicted Cancers in Presentation at 40th Annual J.P. Morgan Healthcare Conference,1/11/2022 8:15:00 PM
RVMD,"Revolution Medicines to Provide R&D Update, Including Expansion of Development-Stage RAS(ON) Inhibitor Pipeline, During Presentation at 40th Annual J.P. Morgan Healthcare Conference",1/4/2022 1:30:00 PM
RVMD,"Alnylam, Crispr Therapeutics among Goldman's biopharma M&A targets for 2022",12/19/2021 2:00:00 PM
RVMD,Revolution Medicines to Participate in 4th Annual Evercore ISI HealthCONx Conference,11/24/2021 1:30:00 PM
RVMD,Revolution Medicines Reports Third Quarter Financial Results and Update on Corporate Progress,11/10/2021 10:05:00 PM
RVMD,Revolution Medicines is about to announce its earnings — here's what Wall Street expects,11/9/2021 3:01:13 PM
RVMD,Revolution Medicines to Participate in Stifel 2021 Virtual Healthcare Conference,11/8/2021 10:05:00 PM
RVMD,"Revolution Medicines to Report Financial Results for Third Quarter 2021 After Market Close on November 10, 2021",11/3/2021 9:05:00 PM
RVMD,It's a Done Deal: 365 Cannabis Sold to Akerna,10/11/2021 10:06:11 PM
RVMD,Revolution Medicines to Present New Preclinical Data from RAS(ON) Inhibitor Programs at AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics,9/30/2021 1:30:00 PM
RVMD,Revolution Medicines to Participate in 3rd Annual RAS-Targeted Drug Development Summit,9/15/2021 1:30:00 PM
RVMD,Revolution Medicines to Present at H.C. Wainwright 23rd Annual Global Investment Conference,9/7/2021 10:05:00 PM
RVMD,"The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO",8/13/2021 1:43:02 PM
RVMD,54 Stocks Moving In Thursday's Mid-Day Session,8/12/2021 6:08:00 PM
RVMD,Revolution Medicines Reports Second Quarter Financial Results and Update on Corporate Progress,8/11/2021 10:01:00 PM
RVMD,Here's what Wall Street expects from Revolution Medicines's earnings,8/9/2021 3:02:04 PM
RVMD,"The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight",8/8/2021 4:11:24 PM
RVMD,"Revolution Medicines to Report Financial Results for Second Quarter 2021 After Market Close on August 11, 2021",8/4/2021 10:05:00 PM
RVMD,Revolution Medicines Announces Publication of Scientific Paper Describing Novel Class of Anti-Tumor Compounds Targeting mTORC1,6/24/2021 10:05:00 PM
RVMD,Revolution Medicines to Host Science Talk Webcast Highlighting Learnings from Recent Preclinical and Clinical Studies of RAS Inhibitors,6/10/2021 1:30:00 PM
RVMD,Revolution Medicines to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference,6/2/2021 1:30:00 PM
RVMD,"The Daily Biotech Pulse: Biohaven, Bristol-Myers Squibb Snag FDA Approvals, Iterum UTI Drug Review On Track, Centessa Pharmaceuticals Debuts On Nasdaq",5/28/2021 2:02:01 PM
RVMD,"Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2021",5/18/2021 4:05:31 PM
RVMD,10 Biggest Price Target Changes For Tuesday,5/11/2021 1:49:07 PM
RVMD,Revolution Medicines Reports First Quarter Financial Results and Update on Corporate Progress,5/10/2021 10:05:00 PM
RVMD,Revolution Medicines Highlights Slate of Diverse Board of Directors Nominees for Upcoming 2021 Annual Shareholder Meeting,5/3/2021 1:05:00 PM
RVMD,Revolution Medicines expects no data from Amgen-sponsored clinical trial for RMC-4630,4/30/2021 11:35:10 AM
RVMD,60 Biggest Movers From Yesterday,4/29/2021 11:21:32 AM
RVMD,41 Stocks Moving In Wednesday's Mid-Day Session,4/28/2021 6:06:35 PM
RVMD,Revolution Medicines Announces Dosing of First Patient in Phase 1/1b Clinical Study of RMC-5552 in Patients with Advanced Solid Tumors,4/21/2021 1:00:00 PM
RVMD,Revolution Medicines Announces Six Presentations at the American Association for Cancer Research Annual Meeting 2021,3/11/2021 10:05:00 PM
RVMD,Revolution Medicines to Participate in Upcoming Investor Conferences,3/9/2021 1:30:00 PM
RVMD,Revolution Medicines Reports Fourth Quarter and Year-End 2020 Financial Results and Update on Corporate Progress,3/2/2021 10:05:00 PM
RVMD,Revolution Medicines to Participate in Digital RAS-Targeted Drug Discovery Summit and Upcoming Investor Conferences,2/18/2021 1:30:00 PM
RVMD,Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of  Underwriters' Option to Purchase Additional Shares,2/8/2021 10:01:00 PM
RVMD,"The Daily Biotech Pulse: J&J Files For COVID-19 Vaccine Approval, Zimmer Biomet's Spin-Off, IPO Deluge Hits Street",2/5/2021 1:44:38 PM
RVMD,"The Daily Biotech Pulse: Novartis COVID-19 Drug Readout, Merck And Roche Earnings, 3 IPOs",2/4/2021 1:21:58 PM
RVMD,8 Stocks Moving In Monday's After-Hours Session,2/1/2021 10:58:30 PM
RVMD,"Revolution Medicines to Provide R&D Pipeline Update, Including Progress of RAS(ON) Inhibitor Programs, During Presentation at 39th Annual J.P. Morgan Healthcare Conference",1/5/2021 1:30:00 PM
RVMD,Revolution Medicines Reports Third Quarter 2020 Financial Results and Update on Corporate Progress,11/12/2020 1:30:00 PM
RVMD,"SAP, DNKN, CODX and NNDM among midday movers",10/26/2020 4:38:50 PM
RVMD,Revolution Medicines Reports Progress and Expansion of Combination Strategy with RMC-4630 as Therapeutic Backbone for RAS-Addicted Cancers,10/24/2020 3:45:10 PM
RVMD,Revolution Medicines to present interim data from early-stage cancer study in an upcoming symposium,10/12/2020 2:46:36 PM
RVMD,Revolution Medicines Reports Preclinical Tumor Regressions Induced by First-in-Class KRAS-G12D(ON) Inhibitors,9/16/2020 3:00:10 PM
RVMD,Revolution Medicines to Present at the H.C. Wainwright 22nd Annual Global Investment Conference,9/9/2020 1:30:10 PM
RVMD,Revolution Medicines to Participate in 2nd Annual RAS-Targeted Drug Development Conference,9/8/2020 1:30:10 PM
RVMD,Revolution Medicines Reports Second Quarter 2020 Financial Results and Provides Update on Corporate Progress,8/10/2020 1:30:10 PM
RVMD,Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares,7/13/2020 10:01:10 PM
RVMD,Revolution Medicines Announces Pricing of $156.0 Million Public Offering of Common Stock,7/9/2020 4:48:43 AM
RVMD,Revolution Medicines Announces Proposed Public Offering of Common Stock,7/6/2020 10:01:10 PM
RVMD,Revolution Medicines Reports New Application of Tri-Complex Modality for “Undruggable” Protein Targets and Announces License to Ginkgo Bioworks to Explore Potential Use Against Novel Coronavirus,6/30/2020 10:05:10 PM
RVMD,Revolution Medicines Provides Research and Development Update for its Portfolio of Novel Targeted Cancer Therapies,6/22/2020 10:01:10 PM
RVMD,"Revolution Medicines Appoints Eric T. Schmidt, Ph.D. and Peter Svennilson to its Board of Directors",6/18/2020 1:30:10 PM
RVMD,Revolution Medicines Announces Dosing of First Patient in Phase 1b Combination Study of RMC-4630 and AMG 510,6/9/2020 1:30:10 PM
RVMD,Revolution Medicines Announces Four Presentations at the 2020 American Association for Cancer Research Virtual Annual Meeting II,5/19/2020 1:30:10 PM
RVMD,Revolution Medicines Reports First Quarter 2020 Financial Results and Continued Corporate Progress,5/14/2020 10:05:10 PM
RVMD,Revolution Medicines Announces Publication of Scientific Paper Describing Anti-Tumor Immunity Induced by SHP2 Inhibitor in Preclinical Cancer Models,4/29/2020 2:05:10 PM
RVMD,Revolution Medicines nabs new patent in U.S.,3/18/2020 12:53:21 PM
RVMD,New Clinical Trial Exploring Revolution Medicines’ Investigational SHP2 Inhibitor RMC-4630 in Combination with an ERK Inhibitor Announced by Netherlands Cancer Institute,3/9/2020 12:30:00 PM
RVMD,Revolution Medicines Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares,2/18/2020 10:01:00 PM
RVMD,Revolution Medicines Announces Pricing of Initial Public Offering,2/13/2020 1:38:58 AM
